| Autor: |
Shah Hosseini, Reza, Nouri, Seyed Mohammad, Bansal, Pooja, Hjazi, Ahmed, Kaur, Harpreet, Hussein Kareem, Anaheed, Kumar, Abhinav, Al Zuhairi, Rafil Adnan Hussein, AL-Shaheri, Nadhim Allawi, Mahdavi, Parya |
| Předmět: |
|
| Zdroj: |
DNA & Cell Biology; Nov2024, Vol. 43 Issue 11, p549-558, 10p |
| Abstrakt: |
One of the main health issues in the modern world is cancer, with breast cancer (BC) as one of the most common types of malignancies. Different environmental and genetic risk factors are involved in the development of BC. One of the primary genes implicated in cancer development is the p53 gene, which is also known as the "gatekeeper" gene. p53 is involved in cancer development by interacting with numerous pathways and signaling factors, including microRNAs (miRNAs). miRNAs are small noncoding RNA molecules that regulate gene expression by binding to the 3′ untranslated region of target mRNAs, resulting in their translational inhibition or degradation. If the p53 gene is mutated or degraded, it can contribute to the risk of BC by disrupting the expression of miRNAs. Similarly, the disruption of miRNAs causes the negative regulation of p53. Therefore, the p53/miRNA axis is a crucial pathway in the progression or prevention of BC, and understanding the regulation and function of this pathway may contribute to the development of new therapeutic strategies to help treat BC. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
